← Leaderboards
Michael Darin Cameron
Scripps Research Institute, The
$4,952,970
Attributed
$7,427,581
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2008–24$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,927,698 · 7
CDC$499,883 · 1
By mechanism
U01$3,931,502 · 2
S10$946,447 · 2
R56$810,158 · 1
U54$635,981 · 1
P01$569,388 · 1
R21$534,105 · 1
Top collaborators
- Edward Roberts4 shared
- Sevan Najm Alwan1 shared
- Thomas D Bannister1 shared
- Philip T Loverde1 shared
- Stanton Furst Mchardy1 shared
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Theodore M Kamenecka$11,110,151
- Jonathan Alan Hollander$446,034
- Edward Roberts$6,084,768
- Brooke E Schmeichel$1,359,872
- Pietro P Sanna$50,542,929
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroLaboratoriesIn VivoDesignRattusPre-ClinicalCellsDrug DiscoveryPropertyPharmaceutical ChemistryEvaluationBaseDrug KineticsDoseReceptorDrug InteractionsStagingPermeabilityEfficacy TestingMetabolicPharmacologyAnimalsIn Vitro AssayValidation
Grant awards (14)
Preclinical Testing of Potential Next-generation Antischistosomal Compounds$810,158
R56 · FY2024 · AI
Sciex 6500+ QTrap Mass Spectrometer$485,845
S10 · FY2021 · OD · contact PI
Validation of non-electrophile Nrf2 activators for WTC relevant pulmonary indications$499,883
U01 · FY2020 · OH · contact PI
Optimizing Drug-like Properties$283,677
P01 · FY2014 · DA · contact PI
Discovery of potent and selective neuropeptide Y Y2 receptor antagonist probes$773,574
U01 · FY2013 · AA · contact PI
Mass spectrometry for small molecule profiling in the Scripps Florida DMPK core$460,602
S10 · FY2013 · OD · contact PI
Characterization of a Novel Selective Cytochrome P450 3A5 Substrate$286,605
R21 · FY2013 · DK · contact PI
Optimizing Drug-like Properties$285,711
P01 · FY2013 · DA · contact PI
Discovery of potent and selective neuropeptide Y Y2 receptor antagonist probes$862,395
U01 · FY2012 · AA · contact PI
Characterization of a Novel Selective Cytochrome P450 3A5 Substrate$247,500
R21 · FY2012 · DK · contact PI
Discovery of potent and selective neuropeptide Y Y2 receptor antagonist probes$888,550
U01 · FY2011 · AA · contact PI
Discovery of potent and selective neuropeptide Y Y2 receptor antagonist probes$907,100
U01 · FY2010 · AA
Pharmacokinetics (Florida)$320,513
U54 · FY2009 · MH · contact PI
Pharmacokinetics (Florida)$315,468
U54 · FY2008 · MH · contact PI